BXDC launched its analyst coverage era this week, drawing initiations from ten firms in two days — and the divide between bulls and sideliners defines the story heading into the stock's first full trading weeks as a covered name.
The initiation wave is the standout event. Morgan Stanley kicked off coverage on June 10 with an Equal-Weight and a $23 target, one day after nine other firms piled in on June 8. The direction of travel is mixed rather than bullish: JPMorgan, Citigroup, BofA Securities, and MoffettNathanson all came in at Neutral, while Wells Fargo (Overweight, $26) and Barclays (Overweight, $24) took the other side. Deutsche Bank and RBC split toward Buy and Outperform respectively. The consensus lands at Hold, with a mean target of $24.05 against a current price of $22.31 — implying roughly 8% upside, but only if the bullish minority is right. The spread between the lowest target ($21, MoffettNathanson) and the highest ($26, Wells Fargo) reflects genuine disagreement about how quickly digital infrastructure demand — driven by AI compute buildout — translates into distributable cash flow for a trust this early in its life.
The lending market offers no drama to set against that uncertainty. Borrow availability is extremely loose at roughly 1,679% — meaning there are around 13.7 million shares available to borrow against fewer than 490,000 actually shorted. Short interest has nudged down about 4% on the week, running below 510,000 shares. With a cost to borrow near 0.52%, well below 1%, there is no short-side pressure building at all. That is a notable contrast to mid-May, when borrow costs briefly spiked above 29% and availability compressed to roughly 43% — a moment that has since unwound almost entirely. The ORTEX short score of 28.5 is at the low end of its recent range, consistent with a stock that bears are not particularly interested in right now.
The insider picture from the IPO is worth flagging. On May 15 — the same date the stock priced at $20 — every layer of the company bought in. An affiliated Blackstone entity took 9.1 million shares for $182 million. Stephen Schwarzman added 375,000 shares for $7.5 million. President and CEO Nicholas Pell bought 25,000 shares, CFO Anthony Marone bought 10,000, and directors including Katharine Keenan added positions. Net insider buying across the 90-day window totals over 9.5 million shares and roughly $191 million in value. The caveat is that IPO-date insider purchases are structurally different from open-market buys made months after listing — they are part of the capital raise, not independent market signals. Still, the scale of Blackstone's affiliated commitment at the offer price is notable: the stock is now trading 11.5% above that level.
Valuation context is limited given the trust's brief public history. The PE multiple registers at 92.8x on trailing earnings, and the price-to-book ratio is 1.25x. Neither figure is particularly meaningful without a forward FFO run-rate, which analysts will be establishing over the coming quarters. The dividend yield implied by the DPS/Price ratio is roughly 2.2%. The week's 1.9% gain brings the stock to $22.31, building steadily off the $20 offer.
With no earnings event scheduled yet, the immediate catalyst calendar is the analyst initiation digest itself — how institutional money responds to a Hold-heavy coverage start from the Street, and whether the Wells Fargo and Barclays bull case around AI-driven data center demand gains traction or gets weighted down by the Neutral majority's more cautious read on near-term FFO visibility.
See the live data behind this article on ORTEX.
Open BXDC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
